Archive for the 'Lymphoma / Leukemia' Category
Novartis Drug Tasigna® Approved In Switzerland After Fast-track Review For Treatment Of Patients With Newly Diagnosed Ph+ CML
The Swiss health authority Swissmedic has granted approval for Tasigna® (nilotinib) 300 mg twice daily for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase…Original post by Lemonade Life
No commentsTaking Aim At Pre-Leukemia Disorders: NewYork-Presbyterian/Columbia Establishes Myelodysplastic Syndromes Center
NewYork-Presbyterian Hospital/Columbia University Medical Center has established a new center devoted to research and treatment of pre-leukemia blood disorders. Known as the Myelodysplastic Syndromes Center, it is one of the largest programs of its kind in the nation. Myelodysplastic syndromes (MDS) are disorders interfering with blood production in the bone marrow…Original post by Pharmalot
No commentsExtensive Trial Confirms Benefits Of Early Steroid Withdrawal For Transplant Patients
A University of Cincinnati (UC) analysis of 10 years of data from local kidney transplant patients shows that patients removed from a corticosteroid regimen shortly after surgery have better graft survival rates, better survival rates and fewer cardiovascular events than patients kept on the traditional regimen of long-term steroids…Original post by Consumer Reports Health Blog
No commentsLink Between Blood Stem Cell And Leukemia Illuminated In UCSF-Led Study
A UCSF-led team has discovered at least one key reason why blood stem cells are susceptible to developing the genetic mutations that can lead to adult leukemia. Their finding also may explain, they say, why some other age-related hematological disorders develop…Original post by Six Until Me.
No commentsEMEA Validates Cell Therapeutics, Inc.’s (CTI) Expanded Pixantrone Pediatric Investigation Plan (PIP)
Cell Therapeutics, Inc. (”CTI”) (Nasdaq and MTA: CTIC) announced that it has received notice that the European Medicines Agency (”EMEA”) has validated the expanded Pediatric Investigation Plan (”PIP”) that CTI filed in July for pixantrone for the treatment of relapsed or refractory, aggressive non-Hodgkin’s lymphoma (NHL)…Original post by Six Until Me.
No commentsMesoblast Limited (ASX:MSB) On Track For Phase 3 Bone Marrow Transplant Trial Following Positive Meeting With United States FDA
Australian regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY), today provided market guidance on its Phase 3 bone! marrow transplant program following a formal meeting with the! United States Food and Drug Administration (FDA)…Original post by Diabetes Daily
No commentsTechnique To Preserve Fertility In Young Women May Be Unsafe For Patients With Leukemia
Although the use of ovarian tissue cryopreservation and transplantation has lead to 13 live births in women with lymphoma or solid tumors, this method of fertility preservation may be unsafe for patients with leukemia, according to a recent study published online in Blood, the journal of the American Society of Hematology…Original post by Diabetes Daily
No commentsUnderstanding How Blood Stem Cells Are Maintained Within The Niche Offers New Opportunities To Exploit Them Therapeutically
Hematopoietic stem cells (HSCs) have two unique abilities that are prized by medical researchers: to self-renew and to develop into any kind of blood cell, which enables them to replenish the entire blood and immune system…Original post by Balanced Health and Nutrition Rebecca Scritchfield’s Blog
No commentsGenmab Announces Top-Line Interim Results For Ofatumumab In Diffuse Large B-Cell Lymphoma
Genmab A/S (OMX: GEN) announced today top-line interim results from an initial Phase II single arm open label study of ofatumumab to evaluate the treatment of relapsed Diffuse Large B-Cell Lymphoma (DLBCL) in patients ineligible for or relapsed following a stem cell transplant…Original post by Lemonade Life
No commentsFamilial Link In Rare Childhood Leukemia
A UCSF-led team has discovered a direct link between an inherited genetic mutation, a set of developmental abnormalities and a rare form of childhood leukemia called juvenile myelomonocytic leukemia, or JMML. The study demonstrates a new familial link in JMML and has significant implications, the researchers say, for improving the diagnosis and treatment of the disease…Original post by Diabetes Mine
No comments